ArticleThe Analyst2016

Microfluidics for the detection of minimal residual disease in acute myeloid leukemia patients using circulating leukemic cells selected from blood.

Joshua M Jackson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.